Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE)
Satoshi Kuroda,Shusuke Yamamoto,Takeshi Funaki,Miki Fujimura,Hiroharu Kataoka,Tomohito Hishikawa,Jun Takahashi,Hidenori Endo,Tadashi Nariai,Toshiaki Osato,Nobuhito Saito,Norihiro Sato,Emiko Hori,Yoichi M. Ito,Susumu Miyamoto,Motoki Inaji,Kenichi Morita,Daisuke Maruyama,Jyoji Nakagawara,Naoki Hashimura,Eika Hamano,Koji Iihara,Nobuo Hashimoto,Kaori Honjo,Hirohiko Nakamura,Daina Kashiwazaki,Hideaki Imai,Satoru Miyawaki,Hiroki Hongo,Kazumichi Yoshida,Takayuki Kikuchi,Yohei Mineharu,Makoto Isozaki,Kenichiro Kikuta,Yoshio Araki,Fumiaki Kanamori,Isao Date,Junichi Ono,Toshio Machida,Mitsuhito Mase,Hiroyuki Katano,Koji Yamaguchi,Takakazu Kawamata,Teiji Tominaga,Haruto Uchino,Kikutaro Tokairin,Masaki Ito,Kiyohiro Houkin,Kohei Chida,Kuniaki Ogasawara,Izumi Nagata,Nobutaka Horie,Hidehiro Oka,Toshihiro Kumabe,Yoshiaki Itoh,Takato Abe,Koichi Oki,Shinichi Takahashi,Norihiro Suzuki
DOI: https://doi.org/10.1161/STROKEAHA.122.041932
IF: 10.17
2023-05-24
Stroke
Abstract:Stroke, Volume 54, Issue 6, Page 1494-1504, June 1, 2023. Background:Long-term outcomes are unknown in patients with asymptomatic moyamoya disease. In this report, we aimed to clarify their 5-year risk of stroke and its predictors.Methods:We are conducting a multicenter, prospective cohort study (Asymptomatic Moyamoya Registry) in Japan. Participants were eligible if they were 20 to 70 years, had bilateral or unilateral moyamoya disease, experienced no episodes suggestive of TIA and stroke; and were functionally independent (modified Rankin Scale score 0–1). Demographic and radiological information was collected at enrollment. In this study, they are still followed up for 10 years. In this interim analysis, we defined the primary end point as a stroke occurring during a 5-year follow-up period. Independent predictors for stroke were also determined, using a stratification analysis method.Results:Between 2012 and 2015, we enrolled 109 patients, of whom 103 patients with 182 involved hemispheres completed the 5-year follow-up. According to the findings on DSA and MRA, 143 hemispheres were judged as moyamoya disease and 39 hemispheres as questionable manifestations (isolated middle cerebral artery stenosis). The patients with questionable hemispheres were significantly older, more often male, and more frequently had hypertension than those with moyamoya hemisphere. Moyamoya hemispheres developed 7 strokes, including 6 hemorrhagic and 1 ischemic stroke, during the first 5 years. The annual risk of stroke was 1.4% per person, 0.8% per hemisphere, and 1.0% per moyamoya hemisphere. Independent predictor for stroke was Grade-2 choroidal anastomosis (hazard ratio, 5.05 [95% CI, 1.24–20.6];P=0.023). Furthermore, microbleeds (hazard ratio, 4.89 [95% CI, 1.13-21.3];P=0.0342) and Grade-2 choroidal anastomosis (hazard ratio, 7.05 [95% CI, 1.62–30.7];P=0.0093) significantly predicted hemorrhagic stroke. No questionable hemispheres developed any stroke.Conclusions:The hemispheres with asymptomatic moyamoya disease may carry a 1.0% annual risk of stroke during the first 5 years, the majority of which are hemorrhagic stroke. Grade-2 choroidal anastomosis may predict stroke, and the microbleeds and Grade-2 choroidal anastomosis may carry the risk for hemorrhagic stroke.Registration:URL:https://www.clinicaltrials.gov; Unique identifier: UMIN000006640.
peripheral vascular disease,clinical neurology